These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 8571133)

  • 21. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
    Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
    Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of ceramide production reverses TNF-induced insulin resistance.
    Grigsby RJ; Dobrowsky RT
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1121-4. PubMed ID: 11587538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
    Carvalho-Filho MA; Ueno M; Carvalheira JB; Velloso LA; Saad MJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E476-82. PubMed ID: 16638822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
    Henriksen EJ; Teachey MK
    Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways.
    Motoshima H; Araki E; Nishiyama T; Taguchi T; Kaneko K; Hirashima Y; Yoshizato K; Shirakami A; Sakai K; Kawashima J; Shirotani T; Kishikawa H; Shichiri M
    Diabetes Res Clin Pract; 2000 Jun; 48(3):155-70. PubMed ID: 10802154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells.
    del Aguila LF; Claffey KP; Kirwan JP
    Am J Physiol; 1999 May; 276(5):E849-55. PubMed ID: 10329978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
    Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
    Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling.
    Yamaguchi K; Higashiura K; Ura N; Murakami H; Hyakukoku M; Furuhashi M; Shimamoto K
    Hypertens Res; 2003 May; 26(5):389-96. PubMed ID: 12887130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).
    Aguirre V; Uchida T; Yenush L; Davis R; White MF
    J Biol Chem; 2000 Mar; 275(12):9047-54. PubMed ID: 10722755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of insulin receptor substrate-1 serine 307 phosphorylation and adiponectin in adipose tissue insulin resistance in late pregnancy.
    Sevillano J; de Castro J; Bocos C; Herrera E; Ramos MP
    Endocrinology; 2007 Dec; 148(12):5933-42. PubMed ID: 17823255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
    Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
    Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganglioside GM3 participates in the pathological conditions of insulin resistance.
    Tagami S; Inokuchi Ji J; Kabayama K; Yoshimura H; Kitamura F; Uemura S; Ogawa C; Ishii A; Saito M; Ohtsuka Y; Sakaue S; Igarashi Y
    J Biol Chem; 2002 Feb; 277(5):3085-92. PubMed ID: 11707432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity.
    Araújo EP; De Souza CT; Gasparetti AL; Ueno M; Boschero AC; Saad MJ; Velloso LA
    Endocrinology; 2005 Mar; 146(3):1428-37. PubMed ID: 15550510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists.
    Fernández-Veledo S; Vila-Bedmar R; Nieto-Vazquez I; Lorenzo M
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3583-93. PubMed ID: 19567513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Elucidation of a New Mechanism of Onset of Insulin Resistance: Effects of Statins and Tumor Necrosis Factor-α on Insulin Signal Transduction].
    Takaguri A
    Yakugaku Zasshi; 2018; 138(11):1329-1334. PubMed ID: 30381640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice.
    Li J; Houseknecht KL; Stenbit AE; Katz EB; Charron MJ
    FASEB J; 2000 Jun; 14(9):1117-25. PubMed ID: 10834933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro.
    Méndez-García LA; Trejo-Millán F; Martínez-Reyes CP; Manjarrez-Reyna AN; Esquivel-Velázquez M; Melendez-Mier G; Islas-Andrade S; Rojas-Bernabé A; Kzhyshkowska J; Escobedo G
    Scand J Immunol; 2018 Nov; 88(5):e12716. PubMed ID: 30260514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.